Login Register Cart 0
Generic placeholder image

Combinatorial Chemistry & High Throughput Screening

Editor-in-Chief

ISSN (Print): 1386-2073
ISSN (Online): 1875-5402

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Green Alternatives in Pharmaceutical and Bioanalytical Analysis of TDM Required Drugs: Procainamide

Author(s): Murat Ülgen, Cemil Can Eylem, Aysegul Dogan and Nursabah Elif Basci Akduman*

Volume 26, Issue 15, 2023

Published on: 19 May, 2023

Page: [2656 - 2667] Pages: 12

DOI: 10.2174/1386207326666230331083215

Price: $65

Abstract

Introduction: In drug analysis, using non-hazardous solvents instead of the ones harmful to humans and the environment is a green strategy to protect analysts and environmental health.

Objective: Procainamide (PCA) is an antiarrhythmic drug requiring therapeutic drug monitoring (TDM) because of its narrow therapeutic window and serious side effects.

Aim: The aim of this study is to develop validated green HPLC methods to be used in drug quality control and TDM analysis for PCA, thus indicating the further applicability in the analysis of TDM-required drugs, such as immunosuppressants, anti-cancer drugs, and psychiatric drugs.

Methods: Human-friendly ethanol was selected as an organic solvent in the mobile phase. PCA was eluted from NUCLEODUR 100-5 C8 ec (5 μm, 150 x 4.6 mm) column by a mobile phase containing ethanol and 50 mM NaH2PO4 buffer (5:95, v/v). The mobile phase flow rate was 1.0 ml min-1, the column temperature was 35 °C, and the wavelength at the PDA detector was 278 nm.

Results: Retention time for PCA was 5.0 min and 7.7 min for paracetamol as an internal standard (IS). In the green HPLC method for pharmaceutical analysis, the highest relative standard deviation (RSD) and mean recovery values were 1.32% and 98.89%, respectively. In the analysis of plasma, the sample preparation step was only smooth protein precipitation by ethanol. Thus, the bioanalytical method was fully green having a limit of detection (LOD) of 0.3 μg ml-1 and a limit of quantification (LOQ) of 0.8 μg ml-1. The therapeutic plasma concentration for PCA was reported in the range of 4–12 μg ml-1.

Conclusion: As a result, the green HPLC methods developed and validated in this study were selective, accurate, precise, reproducible, and trustable and have the quality for the application in pharmaceutical and TDM analysis of PCA, thus encouraging green HPLC analysis of other TDM required drugs.

« Previous Next »
Graphical Abstract

[1]
Welch, C.J.; Wu, N.; Biba, M.; Hartman, R.; Brkovic, T.; Gong, X.; Helmy, R.; Schafer, W.; Cuff, J.; Pirzada, Z.; Zhou, L.L. Greening analytical chromatography. Trends Analyt. Chem., 2010, 29(7), 667-680.
[http://dx.doi.org/10.1016/j.trac.2010.03.008]
[2]
Armenta, S.; Garrigues, S.; de la Guardia, M. Green analytical chemistry. Trends Analyt. Chem., 2008, 27(6), 497-511.
[http://dx.doi.org/10.1016/j.trac.2008.05.003]
[3]
de la Guardia, M.; Garrigues, S. Handbook of green analytical chemistry; John Wiley & Sons, 2012.
[http://dx.doi.org/10.1002/9781119940722]
[4]
Płotka, J.; Tobiszewski, M.; Sulej, A.M.; Kupska, M.; Górecki, T.; Namieśnik, J. Green chromatography. J. Chromatogr. A, 2013, 1307, 1-20.
[http://dx.doi.org/10.1016/j.chroma.2013.07.099] [PMID: 23932374]
[5]
Shaaban, H.; Górecki, T. Current trends in green liquid chromatography for the analysis of pharmaceutically active compounds in the environmental water compartments. Talanta, 2015, 132, 739-752.
[http://dx.doi.org/10.1016/j.talanta.2014.09.050] [PMID: 25476373]
[6]
Armenta, S.; de la Guardia, M. Green chromatography for the analysis of foods of animal origin. Trends Analyt. Chem., 2016, 80, 517-530.
[http://dx.doi.org/10.1016/j.trac.2015.06.012]
[7]
Shen, Y.; Chen, B.; van Beek, T.A. Alternative solvents can make preparative liquid chromatography greener. Green Chem., 2015, 17(7), 4073-4081.
[http://dx.doi.org/10.1039/C5GC00887E]
[8]
Assassi, A.L.; Roy, C.E.; Perovitch, P.; Auzerie, J.; Hamon, T.; Gaudin, K. Green analytical method development for statin analysis. J. Chromatogr. A, 2015, 1380, 104-111.
[http://dx.doi.org/10.1016/j.chroma.2014.12.066] [PMID: 25582487]
[9]
Funari, C.S.; Carneiro, R.L.; Cavalheiro, A.J.; Hilder, E.F. A trade off between separation, detection and sustainability in liquid chromatographic fingerprinting. J. Chromatogr. A, 2014, 1354, 34-42.
[http://dx.doi.org/10.1016/j.chroma.2014.05.018] [PMID: 24952659]
[10]
Cheregi, M.; Albu, F. Udrescu, Ş.; Răducanu, N.; Medvedovici, A. Greener bioanalytical approach for LC/MS–MS assay of enalapril and enalaprilat in human plasma with total replacement of acetonitrile throughout all analytical stages. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2013, 927, 124-132.
[http://dx.doi.org/10.1016/j.jchromb.2012.11.023] [PMID: 23266124]
[11]
Tache, F.; Udrescu, S.; Albu, F. Micăle, F.; Medvedovici, A. Greening pharmaceutical applications of liquid chromatography through using propylene carbonate–ethanol mixtures instead of acetonitrile as organic modifier in the mobile phases. J. Pharm. Biomed. Anal., 2013, 75, 230-238.
[http://dx.doi.org/10.1016/j.jpba.2012.11.045] [PMID: 23277155]
[12]
Paul, O.; Leigh, C.G. Ventricular tachycardia: treatment with very large doses of procaine amide. Med. Clin. North Am., 1966, 50(1), 271-278.
[http://dx.doi.org/10.1016/S0025-7125(16)33234-5] [PMID: 5906563]
[13]
Patton, R.D.; Pattrn, E.; Stein, E.; Damato, A.N. Large doses of procainamide for paroxysmal ventricular tachycardia. JAMA, 1969, 209(8), 1221-1222.
[http://dx.doi.org/10.1001/jama.1969.03160210053018] [PMID: 5819679]
[14]
Giardina, E.G.V.; Dreyfuss, J.; Bigger, J.T., Jr; Shaw, J.M.; Schreiber, E.C. Metabolism of procainamide in normal and cardiac subjects. Clin. Pharmacol. Ther., 1976, 19(3), 339-351.
[http://dx.doi.org/10.1002/cpt1976193339] [PMID: 1261169]
[15]
Campbell, T.J.; Williams, K.M. Therapeutic drug monitoring: Antiarrhythmic drugs. Br. J. Clin. Pharmacol., 2001, 52(Suppl. 1), 21S-34S.
[PMID: 11564050]
[16]
Rocco, R.M.; Abbott, D.C.; Giese, R.W.; Karger, B.L. Analysis for procainamide and N-acetyl procainamide in plasma or serum by high-performance liquid chromatography. Clin. Chem., 1977, 23(4), 705-708.
[http://dx.doi.org/10.1093/clinchem/23.4.705] [PMID: 844165]
[17]
Adams, R.F.; Vandemark, F.L.; Scmidt, G. The simultaneous determination of lidocaine and procainamide in serum by use of high pressure liquid chromatography. Clin. Chim. Acta, 1976, 69(3), 515-524.
[http://dx.doi.org/10.1016/0009-8981(76)90126-1] [PMID: 947603]
[18]
Dutcher, J.S.; Strong, J.M. Determination of plasma procainamide and N-acetylprocainamide concentration by high-pressure liquid chromatography. Clin. Chem., 1977, 23(7), 1318-1320.
[http://dx.doi.org/10.1093/clinchem/23.7.1318] [PMID: 872378]
[19]
Carr, K.; Woosley, R.L.; Oates, J.A. Simultaneous quantification of procainamide and n-acetylprocainamide with high-performance liquid chromatography. J. Chromatogr. A, 1976, 129, 363-368.
[http://dx.doi.org/10.1016/S0021-9673(00)87796-1] [PMID: 1002795]
[20]
Pharmacopeia, U. United States Pharmacopeia and National Formulary. USP 37–NF 32; US Pharmacopeia: Rockville, MD, 2014.
[21]
Commission, E.P. European Pharmacopoeia Ninth Edition (PhEur 9.0); European Directorate for the Quality of Medicines: Strasbourg, France, 2016.
[22]
Uslu, B.; Nemutlu, E. Şener, E.; Karadeniz, H.; Çelik, H.; Şatana Kara, H. E.; Çelebier, M. Turkish Pharmacopoeia 2017, Republic of Turkey Ministry of Health Turkish Medicines and Medical Devices Agency, 2017.
[23]
Guideline, I. H. T. Validation of analytical procedures: text and methodology.Q2 (R1), 2005, 1, pp. 1-15.
[24]
FDA. Guidance for industry: bioanalytical method validation. 2001. Available from: http://www.fda.gov/cder/Guidance/4252fnl.pdf
[25]
Monographs, U.S.P. (MDCV05) Monograph Development-Cardiovascular, USP29–NF24, 1804. Pharmacop. Forum, 2006, 29(5)
[26]
Gaber, Y.; Törnvall, U.; Kumar, M.A.; Ali Amin, M.; Hatti-Kaul, R. HPLC-EAT (Environmental Assessment Tool): A tool for profiling safety, health and environmental impacts of liquid chromatography methods. Green Chem., 2011, 13(8), 2021-2025.
[http://dx.doi.org/10.1039/c0gc00667j]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy